EFM
TCRT icon

E Fund Management’s Alaunos Therapeutics TCRT Stock Holding History

E Fund Management’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-101
Closed -$26K – 352
2022
Q3 		$26K Buy
+101
New +$29.3K ﹤0.01% 333
2022
Q1 		– Sell
-180
Closed -$29K – 355
2021
Q4 		$29K Buy
180
+29
+19% +$6.37K ﹤0.01% 300
2021
Q3 		$41K Buy
+151
New +$46.2K ﹤0.01% 268
2021
Q1 		$81K Buy
+150
New +$93.4K 0.01% 247

Other funds holding TCRT

DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Addison Capital Conshohocken, Pennsylvania $562M AUM 18.57% 1-Year Est. Return
SGCA
Steel Grove Capital Advisors Memphis, Tennessee $949M AUM 23.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

E Fund Management's TCRT Position: Q4 2022 in Review

E Fund Management sold out of Alaunos Therapeutics (TCRT) in Q4 2022, closing a stake of 101 shares — an estimated $26K sold.

E Fund Management first reported a position in TCRT in Q1 2021 and held it in 4 quarters. The position peaked at $81K in Q1 2021. 122 funds tracked by Wall St. Rank hold TCRT as of Q4 2022.

  • E Fund Management reported no remaining Alaunos Therapeutics position as of Q4 2022 after selling out during the quarter.
  • E Fund Management sold 101 Alaunos Therapeutics shares in Q4 2022, an estimated $26K.
  • E Fund Management first reported a position in Alaunos Therapeutics in Q1 2021 and held it in 4 quarters.
  • E Fund Management's Alaunos Therapeutics position peaked at $81K in Q1 2021.
  • 122 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q4 2022.

Based on E Fund Management's 13F filing for Q4 2022, filed 14 Feb 2023.